He developed extracorporeal membrane oxygenation, or ECMO, a treatment that can sustain patients whose hearts and lungs are failing — for days or weeks or longer.
Using ECMO in oncology ICU has been questioned after a study revealed persistently high mortality among cancer patients with severe ARDS.